Boston Scientific Corporation has been the subject of 285 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for Harbin Jixianglong Biotech Co., Ltd..
Boston Scientific Corporation: 0 warning letters, 285 recalls, 0 approval records, 0 Form 483s.
Harbin Jixianglong Biotech Co., Ltd.: 1 warning letter, 0 recalls, 0 approval records, 0 Form 483s.
Side by side
Boston Scientific Corporation — Warning letters0
Harbin Jixianglong Biotech Co., Ltd. — Warning letters1
Boston Scientific Corporation — Recalls285
Harbin Jixianglong Biotech Co., Ltd. — Recalls0
Boston Scientific Corporation — Approval records0
Harbin Jixianglong Biotech Co., Ltd. — Approval records0
Boston Scientific Corporation — Form 483s0
Harbin Jixianglong Biotech Co., Ltd. — Form 483s0
Timeline
Cite this comparison
Pre-formatted for a story, footnote, or reference list:
"Boston Scientific Corporation vs Harbin Jixianglong Biotech Co., Ltd.: FDA Enforcement Comparison." Argus HQ, accessed August 27, 2026. https://argushq.ai/compare/boston-scientific-corporation-vs-harbin-jixianglong-biotech-co-ltd
Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗